Protagonist Therapeutics PTGX Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's shares (basic)?
- Protagonist Therapeutics (PTGX) reported shares (basic) of 65.1M in Q1 2026.
- How has Protagonist Therapeutics's shares (basic) changed year-over-year?
- Protagonist Therapeutics's shares (basic) increased by 3.4% year-over-year, from 63M to 65.1M.
- What is the long-term trend for Protagonist Therapeutics's shares (basic)?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's shares (basic) has grown at a 8.5% compound annual growth rate (CAGR), from 183.4M to 253.8M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.